These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 26261508

  • 21. Xiaoxianggou attenuates atherosclerotic plaque formation in endogenous high Ang II ApoE(-/-) mice via the inhibition of miR-203 on the expression of Ets-2 in endothelial cells.
    Nie W, Zhang X, Yan H, Li S, Zhu W, Fan F, Zhu J.
    Biomed Pharmacother; 2016 Aug; 82():173-9. PubMed ID: 27470353
    [Abstract] [Full Text] [Related]

  • 22. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy.
    Zhang L, Liu Y, Lu XT, Wu YL, Zhang C, Ji XP, Wang R, Liu CX, Feng JB, Jiang H, Xu XS, Zhao YX, Zhang Y.
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2004-14. PubMed ID: 19801495
    [Abstract] [Full Text] [Related]

  • 23. Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE-/- mice.
    Feng M, Zou Z, Zhou X, Hu Y, Ma H, Xiao Y, Li X, Ye X.
    Int Immunopharmacol; 2017 Feb; 43():195-202. PubMed ID: 28024280
    [Abstract] [Full Text] [Related]

  • 24. Tongxinluo enhances the effect of atorvastatin on the treatment of atherosclerosis with chronic obstructive pulmonary disease by maintaining the pulmonary microvascular barrier.
    Kuang X, Wang Y, Liu S, Chang L, Yin Y, Li Z, Liu Y, Li W, Hou Y, Wang H, Liang J, Jia Z.
    Food Sci Nutr; 2023 Jan; 11(1):390-407. PubMed ID: 36655081
    [Abstract] [Full Text] [Related]

  • 25. Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with Lewis Y on endothelial cells.
    Lin WL, Chang CF, Shi CS, Shi GY, Wu HL.
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2366-73. PubMed ID: 23950139
    [Abstract] [Full Text] [Related]

  • 26. Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice.
    Li B, Xu YJ, Chu XM, Gao MH, Wang XH, Nie SM, Yang F, Lv CY.
    Immunol Lett; 2013 Oct; 156(1-2):68-81. PubMed ID: 24084445
    [Abstract] [Full Text] [Related]

  • 27. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
    Liu SL, Li YH, Shi GY, Tang SH, Jiang SJ, Huang CW, Liu PY, Hong JS, Wu HL.
    Cardiovasc Res; 2009 Apr 01; 82(1):161-9. PubMed ID: 19189960
    [Abstract] [Full Text] [Related]

  • 28. Suxiaojiuxin pill enhances atherosclerotic plaque stability by modulating the MMPs/TIMPs balance in ApoE-deficient mice.
    Zhang J, Zhuang P, Lu Z, Zhang M, Zhang T, Zhang Y, Wang J, Liu D, Tong Y.
    J Cardiovasc Pharmacol; 2014 Aug 01; 64(2):120-6. PubMed ID: 24621651
    [Abstract] [Full Text] [Related]

  • 29. Induction of autophagy by Tongxinluo through the MEK/ERK pathway protects human cardiac microvascular endothelial cells from hypoxia/reoxygenation injury.
    Cui H, Li X, Li N, Qi K, Li Q, Jin C, Zhang Q, Jiang L, Yang Y.
    J Cardiovasc Pharmacol; 2014 Aug 01; 64(2):180-90. PubMed ID: 24705173
    [Abstract] [Full Text] [Related]

  • 30. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
    Singh KK, Shukla PC, Quan A, Al-Omran M, Lovren F, Pan Y, Brezden-Masley C, Ingram AJ, Stanford WL, Teoh H, Verma S.
    J Thorac Cardiovasc Surg; 2013 Oct 01; 146(4):949-960.e4. PubMed ID: 23415688
    [Abstract] [Full Text] [Related]

  • 31. The environmental carcinogen benzo[a]pyrene induces expression of monocyte-chemoattractant protein-1 in vascular tissue: a possible role in atherogenesis.
    Knaapen AM, Curfs DM, Pachen DM, Gottschalk RW, de Winther MP, Daemen MJ, Van Schooten FJ.
    Mutat Res; 2007 Aug 01; 621(1-2):31-41. PubMed ID: 17376491
    [Abstract] [Full Text] [Related]

  • 32. Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway.
    Qi K, Li X, Geng Y, Cui H, Jin C, Wang P, Li Y, Yang Y.
    PLoS One; 2018 Aug 01; 13(6):e0198403. PubMed ID: 29912977
    [Abstract] [Full Text] [Related]

  • 33. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways.
    Qin M, Luo Y, Meng XB, Wang M, Wang HW, Song SY, Ye JX, Pan RL, Yao F, Wu P, Sun GB, Sun XB.
    Vascul Pharmacol; 2015 Jul 01; 70():23-34. PubMed ID: 25849952
    [Abstract] [Full Text] [Related]

  • 34. Intervention of Tongxinluo capsule against vascular lesion of atherosclerosis and its effect on lectin-like oxidized low density lipoprotein receptor-1 expression in rabbits.
    Yu YH, Xu XQ, Wang Y, Sun SZ, Chen Y.
    Chin J Integr Med; 2006 Mar 01; 12(1):32-6. PubMed ID: 16571281
    [Abstract] [Full Text] [Related]

  • 35. Preventive effect of Tongxinluo on endothelial survival and vascular integrity, together with inhibition of inflammatory reaction in rats model of intestine ischemia/reperfusion injury.
    Zhang JX, Li SD, Liu Y, Yang MH.
    Pak J Pharm Sci; 2018 Nov 01; 31(6):2403-2410. PubMed ID: 30473511
    [Abstract] [Full Text] [Related]

  • 36. NPRC deletion mitigated atherosclerosis by inhibiting oxidative stress, inflammation and apoptosis in ApoE knockout mice.
    Cheng C, Zhang J, Li X, Xue F, Cao L, Meng L, Sui W, Zhang M, Zhao Y, Xi B, Yu X, Xu F, Yang J, Zhang Y, Zhang C.
    Signal Transduct Target Ther; 2023 Aug 09; 8(1):290. PubMed ID: 37553374
    [Abstract] [Full Text] [Related]

  • 37. Tongxinluo attenuates atherosclerosis by inhibiting ROS/NLRP3/caspase-1-mediated endothelial cell pyroptosis.
    Jiang X, Ma C, Gao Y, Cui H, Zheng Y, Li J, Zong W, Zhang Q.
    J Ethnopharmacol; 2023 Mar 25; 304():116011. PubMed ID: 36529253
    [Abstract] [Full Text] [Related]

  • 38. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V, Mueller CF, Becher UM, Czech T, van Eickels M, Daiber A, Nickenig G, Wassmann S.
    J Mol Cell Cardiol; 2012 Mar 25; 52(3):630-7. PubMed ID: 22230040
    [Abstract] [Full Text] [Related]

  • 39. Akebia Saponin D inhibits the formation of atherosclerosis in ApoE-/- mice by attenuating oxidative stress-induced apoptosis in endothelial cells.
    Yang S, Zhang W, Xuan LL, Han FF, Lv YL, Wan ZR, Liu H, Ren LL, Gong LL, Liu LH.
    Atherosclerosis; 2019 Jun 25; 285():23-30. PubMed ID: 30999121
    [Abstract] [Full Text] [Related]

  • 40. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH.
    Circulation; 2007 May 08; 115(18):2442-50. PubMed ID: 17438151
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.